To test the importance of FGFR4 in hepatocellular carcinoma, we evaluated the effect of its ablation in a genetically engineered mouse model of HCC and assessed the effects of therapeutic FGFR4 neutralization in relevant mouse tumor models. The gene discussed is FGFR4; the disease is neoplasm.